Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2010 1
2012 2
2013 3
2014 6
2015 6
2016 5
2017 6
2018 11
2019 16
2020 14
2021 12
2022 14
2023 9
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Results by year

Filters applied: . Clear all
Page 1
Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression.
Vanhersecke L, Brunet M, Guégan JP, Rey C, Bougouin A, Cousin S, Moulec SL, Besse B, Loriot Y, Larroquette M, Soubeyran I, Toulmonde M, Roubaud G, Pernot S, Cabart M, Chomy F, Lefevre C, Bourcier K, Kind M, Giglioli I, Sautès-Fridman C, Velasco V, Courgeon F, Oflazoglu E, Savina A, Marabelle A, Soria JC, Bellera C, Sofeu C, Bessede A, Fridman WH, Loarer FL, Italiano A. Vanhersecke L, et al. Among authors: pernot s. Nat Cancer. 2021 Aug;2(8):794-802. doi: 10.1038/s43018-021-00232-6. Epub 2021 Aug 12. Nat Cancer. 2021. PMID: 35118423 Free PMC article.
Diarrhoea in adult cancer patients: ESMO Clinical Practice Guidelines.
Bossi P, Antonuzzo A, Cherny NI, Rosengarten O, Pernot S, Trippa F, Schuler U, Snegovoy A, Jordan K, Ripamonti CI; ESMO Guidelines Committee. Bossi P, et al. Among authors: pernot s. Ann Oncol. 2018 Oct 1;29(Suppl 4):iv126-iv142. doi: 10.1093/annonc/mdy145. Ann Oncol. 2018. PMID: 29931177 Free article. No abstract available.
VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors.
Voron T, Colussi O, Marcheteau E, Pernot S, Nizard M, Pointet AL, Latreche S, Bergaya S, Benhamouda N, Tanchot C, Stockmann C, Combe P, Berger A, Zinzindohoue F, Yagita H, Tartour E, Taieb J, Terme M. Voron T, et al. Among authors: pernot s. J Exp Med. 2015 Feb 9;212(2):139-48. doi: 10.1084/jem.20140559. Epub 2015 Jan 19. J Exp Med. 2015. PMID: 25601652 Free PMC article.
[Sequential therapeutic strategy: Promises and difficulties].
Évrard S, Pernot S, Khatib M. Évrard S, et al. Among authors: pernot s. Bull Cancer. 2021 May;108(5):443-445. doi: 10.1016/j.bulcan.2021.02.005. Epub 2021 Apr 10. Bull Cancer. 2021. PMID: 33845993 French. No abstract available.
AGR2 protein expression in colorectal tumour epithelialcompartment.
Chevet E, Bassal F, Beq S, Bonhomme B, Boisteau E, Calloch J, Cazals-Hatem D, Delom F, Fessart D, Evrard S, Hrstka R, Hupp T, Lièvre A, Louis E, Mariau J, Meuwis MA, Ogier-Denis E, Paradis V, Pernot S, Pineau R, Treton X, Velasco V, Vieujean S. Chevet E, et al. Among authors: pernot s. Gut. 2022 Dec 9;72(12):2385-6. doi: 10.1136/gutjnl-2022-328739. Online ahead of print. Gut. 2022. PMID: 36591613 Free PMC article. No abstract available.
Colorectal Cancer: Why Does Side Matter?
Gallois C, Pernot S, Zaanan A, Taieb J. Gallois C, et al. Among authors: pernot s. Drugs. 2018 Jun;78(8):789-798. doi: 10.1007/s40265-018-0921-7. Drugs. 2018. PMID: 29790124 Review.
[Oesogastric cancer - new therapeutic targets].
Palmieri LJ, Soubeyran I, Pernot S. Palmieri LJ, et al. Among authors: pernot s. Bull Cancer. 2023 May;110(5):560-569. doi: 10.1016/j.bulcan.2022.08.005. Epub 2022 Nov 10. Bull Cancer. 2023. PMID: 36371284 Review. French.
[Papillomavirus, could we speak about cancer and prevention?].
Pernot S, Pavie J, Péré H, Menard M, Hurel S, Cochand-Priollet B, Bats AS, Badoual C. Pernot S, et al. Bull Cancer. 2018 Feb;105(2):137-139. doi: 10.1016/j.bulcan.2017.12.001. Epub 2018 Jan 17. Bull Cancer. 2018. PMID: 29373106 French. No abstract available.
Immunomodulatory Activity of VEGF in Cancer.
Lapeyre-Prost A, Terme M, Pernot S, Pointet AL, Voron T, Tartour E, Taieb J. Lapeyre-Prost A, et al. Among authors: pernot s. Int Rev Cell Mol Biol. 2017;330:295-342. doi: 10.1016/bs.ircmb.2016.09.007. Epub 2016 Dec 26. Int Rev Cell Mol Biol. 2017. PMID: 28215534 Review.
Immunotherapy in advanced gastric cancer, is it the future?
Coutzac C, Pernot S, Chaput N, Zaanan A. Coutzac C, et al. Among authors: pernot s. Crit Rev Oncol Hematol. 2019 Jan;133:25-32. doi: 10.1016/j.critrevonc.2018.10.007. Epub 2018 Nov 2. Crit Rev Oncol Hematol. 2019. PMID: 30661655 Review.
92 results